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ABSTRACT  20 
 21 
Bovine viral diarrhoea (BVD) is an economically important cattle disease with a world-wide 22 
distribution that is caused by BVD virus, a pestivirus of the flaviviridae family. BVD viruses 23 
are genetically highly variable. They are classified into two genetic species (BVDV-1 and -24 
2) that are further divided into numerous subgroups, particularly for BVDV-1.  The 25 
complexity of these viruses is also reflected in their interaction with the host animals. 26 
Infections are either transient or persistent and can cause a wide spectrum of clinical 27 
signs, from no or very mild disease to severe forms, reminiscent of viral haemorrhagic 28 
fevers. In this work, we have analysed the clinical signs and the pathology of BVD viral 29 
infections in a cattle population where different subgroups of BVDV-1 genotype viruses are 30 
endemic.  In addition, we have examined potential virulence properties of BVDV-1 31 
subgroups during persistent infection by comparing the viral subgroups present in clinical 32 
cases with those detected in persistently infected (PI) animals sampled for epidemiological 33 
criteria, irrespective of their health condition. Furthermore, the clinical and post mortem 34 
findings were compared with respect to genetic characteristics of the viruses isolated from 35 
these animals.  36 
Our results indicate that the BVDV positive animals fall roughly into two categories, 37 
depending on the primary organ affected and the age, with lung-centred pathology 38 
occurring mainly in young animals and mucosal pathology predominantly in older animals. 39 
Furthermore, we found a markedly higher proportion of representatives of the BVDV-1e 40 
subgroup in stillborn calves and aborted foetuses originating from epidemically unrelated 41 
cattle herds, suggesting that BVDV-1e may play a special role in prenatal and perinatal 42 
losses.  43 
 44 
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INTRODUCTION 48 
 49 
Bovine viral diarrhoea virus (BVDV), classical swine fever virus and border disease virus 50 
form the genus pestivirus within the flaviviridae family. BVD viruses are divided into two 51 
species, BVDV-1 and -2. BVDV-1 strains are particularly diverse, with at least 13 different 52 
subgroups defined genetically (Pellerin et al., 1994; Becher et al., 1997; Vilček et al., 2001; 53 
Becher et al., 2003; Falcone et al., 2003; Vilček et al., 2004; Xu et al., 2006; Jacková et al., 54 
2008) that differ also antigenically as shown by up to tenfold antibody titer differences 55 
between subgroups in crossed neutralization tests (Bachofen et al., 2008). Despite their 56 
diversity, all BVD viruses are either of the cytopathic (cp) or the noncytopathic (ncp) 57 
biotype, as defined by the effect of viral growth in cultured cells. The two biotypes also 58 
differ with respect to their effects in infected animals. Only the ncp biotype can establish a 59 
persistent infection of the foetus if the dam is transiently infected between approximately 60 
days 40 and 120 of its development. Even though such foetuses may develop normally, 61 
they remain infected for life and shed large quantities of virus, thereby assuring the 62 
persistence of BVDV in the cattle population even in the absence of animals susceptible to 63 
transient infection. Different from other persistent viral infections in man and animals, 64 
BVDV persistently infected (PI) cattle are immunotolerant to the infecting viral strain 65 
(reviewed in Peterhans et al., 2006).  66 
The clinical consequences of infection with BVD virus are as diverse as the genetic and 67 
antigenic properties of these viruses. Disease can result from different pathogenetical 68 
mechanisms, depending on the different types of infection. Most transient infections may 69 
take an inapparent or mild course, associated with low-grade fever, diarrhoea and 70 
coughing. Rarely, however, acutely infected animals may suffer from high grade fever and 71 
bleeding in internal organs. This often fatal form of acute infection was reported in 72 
outbreaks in the late 80’s and early 90’s, caused by highly virulent BVD virus-2 strains 73 
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(Ridpath et al., 2000; Ridpath et al., 2006);. Although generally considered to be of low 74 
virulence, BVDV-1, too, may cause similar severe disease signs in acutely infected 75 
animals, albeit only rarely (Liebler-Tenorio et al., 2000; Ridpath et al., 2007;). 76 
In the case of persistent infections, clinical signs in PI animals can be differentiated 77 
pathogenetically into mucosal disease (MD) and non-MD cases. The onset of MD is 78 
associated with the appearance of the cytopathic biotype of BVDV that arises as a result of 79 
mutations and/or recombination events from the persisting ncp virus (Kümmerer et al., 80 
1998; Tautz et al., 1998; Becher et al., 2001). This lethal disease is characterised by 81 
mucosal lesions, destruction of the lymphoid tissue in the gastrointestinal tract (Liebler et 82 
al., 1995) and untreatable diarrhoea. The onset of the clinical signs is often acute but a 83 
more chronic form, called late onset MD, is also described (Liebler-Tenorio et al., 2000; 84 
Fritzemeier et al., 1997). 85 
The clinical signs in PI animals that have not (yet) developed MD can encompass a wide 86 
spectrum of symptoms, ranging from normal health to subclincal disorders, ill-thrift and 87 
growth retardation. Chronic or recurrent intestinal and/or pulmonary symptoms are 88 
frequently observed but occasionally dermatological, neurological or haematological 89 
disorders are the only signs of a persistent infection (Braun et al., 1996; Taylor et al., 90 
1997). In many cases the clinical and necropsy findings do not allow a clear differentiation 91 
between MD and non-MD cases. The isolation of both biotypes, ncp and cp, proves a PI 92 
animal to suffer from MD. 93 
  94 
Possible reasons for the variable clinical signs seen in BVDV infections have been 95 
analysed repeatedly and in some cases an impact of the infecting virus strain was proven 96 
(Baule et al., 1997; Baule et al., 2001; Fulton et al., 2002; Jones et al., 2004; Ridpath et 97 
al., 2007). However, these studies focused on transient infections. Moreover, the analyses 98 
were restricted to single outbreaks of identical or very closely related viral strains that 99 
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affected several animals within one herd or in different herds simultaneously, or to 100 
experimental infections. Hence, the observations may be representative for a given viral 101 
strain rather than for an entire subgroup of BVDV.   102 
In contrast to transient infections, disease associations between individual BVDV strains or 103 
subgroups have not been investigated in persistent infection.  104 
 105 
BVD is endemic in Switzerland, with roughly 60% of cattle seropositive and 0.7% 106 
persistently infected, with seemingly no change in prevalence over a time period of some 107 
30 years (Bürki et al., 1964; Homberger et al., 1975; Rüfenacht et al., 2000; Stalder et al., 108 
2005). In this work, we have analysed PI animals referred by private veterinary 109 
practitioners to the clinical and pathology departments of the veterinary hospital of the 110 
University of Zürich. Due to the endemic nature of BVD, these animals may represent the 111 
most severe clinical forms of persistent infection, comparable to the tip of the iceberg. 112 
We have recorded and applied a scoring protocol for the clinical and post mortem findings 113 
of the diseased animals and analysed possible correlations between different organ 114 
manifestations and the subgroups of persisting BVDV. To obtain an insight into the 115 
possibility of virulence of BVDV in persistent infection, we have analysed the viral 116 
subgroups present in diseased PI animals as compared to subgroups present in animals 117 
diagnosed BVDV PI independently of the clinical status. 118 
 119 
  120 
ANIMALS, MATERIAL AND METHODS 121 
 122 
Patients and examinations 123 
At the Department of Farm Animals of the University of Zurich, all calves less than 3 124 
months of age and chronically diseased animals are routinely tested for the presence of 125 
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BVDV. We have retrospectively analysed all 68 clinical reports of PI animals shown at the 126 
clinic for ruminants from first of January 1995 to 31st of December 2003 (group A, Table 1). 127 
In addition, the 18 prospective cases from the years 2004 and 2005 were included (group 128 
B, Table 1), yielding 86 clinical case reports. All animals had undergone the same 129 
thorough clinical examination following a standardised protocol as described previously 130 
(Braun et al., 1996). Haematological, biochemical, bacteriological and parasitological 131 
analyses were performed as described by Braun et al. (Braun et al., 2007). 132 
The BVDV status of 76 animals of groups A and B was determined intra vitam by 133 
immunohistochemistry (IHC) of skin biopsies (66 cases) and by antigen-capture ELISA of 134 
blood leukocytes (8 cases) (Strasser et al., 1995) or of skin biopsies (2 cases) (Idexx 135 
HerdCheck BVDV Ag/Serum Plus, Idexx Europe B.V., 1119 NE Schiphol-Rijk, The 136 
Netherlands). Some animals were repeatedly tested by multiple methods. Ten animals of 137 
groups A and B were only diagnosed after being euthanised. The BVDV status of all 138 
animals was confirmed post mortem by IHC of organ samples. All samples revealed the 139 
staining pattern typical for persistent infection, as described previously by Hilbe et al. 140 
(2007). 141 
As a result of the unfavourable prognosis, all animals were euthanised within one to 22 142 
days after the initial clinical investigation and sent to the Institute of Veterinary Pathology 143 
for necropsy. A necropsy report was available of 85 of the cases from groups A and B.  In 144 
addition, we included in our study 60 necropsy reports of animals that had been 145 
euthanised or had perished and been submitted by private veterinarians for necropsy to 146 
the Institute of Veterinary Pathology where they were tested BVD virus-positive by IHC of 147 
organ samples (group C, Table 1). The reasons for the submission of these carcasses for 148 
post mortem analysis were variable and encompassed examination of herd problems, 149 
clarification of ambiguous clinical disease signs or suspicion of inherited disease such as 150 
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spinal muscle atrophy of Swiss Brown calves. No information on intra vitam examinations 151 
and their results were available of the animals of group C.  152 
All in all, we analysed 145 necropsy reports (groups A, B, C), 130 of which contained 153 
complete data sets (groups A, B, C.1). In 15 cases, post mortem reports were only 154 
available for single organs or body parts (group C.2, Table 1). 155 
The cases analysed were extended by 25 cases of BVDV infected neonates (stillbirths and 156 
calves younger than three days) and aborted foetuses, tested positive by IHC (staining 157 
pattern typical for persistent infection (group D, Table 1)).  158 
 159 
Recording of reports 160 
Descriptive information from the standardised clinical and necropsy reports was 161 
transformed into ordinal data (e.g. general health condition, degree of lung alteration) or 162 
nominal data (e.g. gender) with the help of a specially created evaluation protocol. The 163 
evaluation protocol applied was created in collaboration with clinicians and pathologists 164 
and is based on clinical scoring protocols used previously (Braun et al., 1996; Braun et al., 165 
2005). For the majority of findings we used a simple 4-level grading: nothing abnormal 166 
detected = 0, mild = 1, moderate = 2, severe alteration = 3. The evaluation of all reports 167 
was performed by the same person and without any information on the BVDV subgroup 168 
isolated from the corresponding PI animal. The scoring was based on the graduation of the 169 
clinical and post mortem findings made by the various clinicians and pathologists who had 170 
initially recorded the cases. Grading the findings is an essential part of the standardised 171 
protocols used for initial clinical examination and necropsy. In those cases where the 172 
organ was only partially affected (e.g. an abscess in a single lung lobe) we considered that 173 
the severity and spread of the lesion would serve to assess the general impairment of the 174 
organ. 175 
 176 
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Mucosal index 177 
To compare the mucosal alterations between different PI animals, we used a standardised 178 
mucosal (mc) index calculated for each animal. This index considers the number of 179 
affected sections of the alimentary tract (from nose to large intestines = max. 7 organs; 180 
affected = any pathological change from the normal tissue integrity) and the severity of the 181 
alterations (0 = no alteration, 1 = mild , 2 = moderate , 3 = severe alteration). With respect 182 
to the multiple dispersed lesions typically seen in MD cases (Liebler-Tenorio et al., 2000) 183 
the calculation places more weight on the number of affected sections than on the severity 184 
of the alterations. The mc index may range from 0 to 21. 185 
 186 
Example: 187 
Mucosal organ score 188 
Muzzle/nose 3 189 
Oral cavity 2 190 
Oesophagus 1 191 
Forestomach 0 192 
Abomasum 2 193 
Small intestines 1 194 
Large intestines 0 195 
∑(mucosal scores) = 9 196 
 197 
Viral genomic sequences 198 
177 Swiss BVDV strains, isolated between 1990 and 2005 were sequenced and 199 
phylogenetically analysed by Stalder et al. (2005). These viruses originated from animals 200 
detected to be PI as a result of a cross-sectional epidemiological study to determine the 201 
∑(mucosal scores)
number of analysed organs
x number of organs with lesionsmc index = 
9
7
x 5  =   6.4mc index = 
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prevalence of BVDV in Switzerland (Rüfenacht, 2001). In addition, viruses were derived 202 
from herd analyses performed in order to assess diagnostic tests or to apply molecular 203 
epidemiology.  204 
The 155 BVDV isolates of the clinical cases described here were isolated, sequenced and 205 
phylogenetically analysed for a study published previously (Bachofen et al., 2008) . 206 
 207 
Statistical analysis 208 
For all statistical calculations the NCSS/PASS software (Kaysville, Utah, USA) was used. 209 
As the data were not normally distributed, we used the non-parametric one-way ANOVA 210 
test (Kruskal-Wallis) to compare medians of three or more groups of patients. If this test 211 
revealed a significant overall difference, pair-wise comparisons were performed using the 212 
Wilcoxon Rank-Sum test. To compare proportions we applied the Chi-square or Fisher’s 213 
exact test. The probability level was set to 95%. The displayed p-values represent the 214 
results of the two-tailed hypothesis testing. 215 
 216 
Determination of biotypes 217 
We tested serum of 14 PI animals from the prospective cases for the existence of 218 
cytopathic BVDV virus as a hallmark for the onset of MD. The sera were diluted seven 219 
times in ten-fold steps in cell culture medium (Earle’s minimal essential medium (MEM)) 220 
enriched with 2% foetal bovine serum (FBS). MEM was purchased from Seromed 221 
(Biochrom, Munich, Germany) and FBS from Sigma or Oxoid GmbH (Wesel, Germany). 222 
FBS was free of BVDV and antibody to BVDV as tested by virus isolation and serum 223 
neutralisation test, respectively. Each serum dilution step was distributed to six wells 224 
(100µl) of a 96-well microtiter plate, seeded with primary bovine turbinate cells. After five 225 
days of incubation at 37°C and 5% CO2, 20µl of supernatant was transferred to a fresh 96-226 
well microtiter plate, pre-seeded with bovine turbinate cells. After addition of 80µl of fresh 227 
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MEM, the microtiter plate was incubated as before and the passaging procedure repeated 228 
once more. After each passage, the cells were fixed and stained for viral protein as 229 
described by Adler et al. (1997). The cells were then microscopically controlled for the 230 
presence of a cytopathic effect. 231 
 232 
 233 
RESULTS 234 
 235 
In order to investigate differences between BVDV subgroups regarding virulence during 236 
persistent infection, clinical recordings and necropsy reports of PI animals infected with 237 
viruses of different BVDV-1 subgroups were analysed. We included patients from the clinic 238 
for ruminants of the Department of Farm Animals (University Zürich) and additional 239 
necropsy reports of animals referred by private veterinarians directly to the Institute of 240 
Veterinary Pathology (University Zürich) for post mortem analysis. 241 
 242 
Groups of patients and anamneses 243 
As shown in Table 1, the cases could be separated into four groups: Retrospective cases 244 
(group A, n = 68) and prospective cases (group B, n = 18) with both a clinical and a 245 
necropsy report, cases directly referred for necropsy by private practitioners without 246 
clinical report (group C, n = 60) and post mortem analyses of abortions and neonates 247 
(animals ≤ 3 days of age) without clinical report (group D, n = 25).  248 
Of the 146 cases of groups A, B and C (abortions and neonates not included since the 249 
gender is often not stated) 78% were females, while for the animals with a clinical report 250 
(groups A and B, n = 86) the proportion of females was 90%.  Animals of five different 251 
breeds and diverse crossbreeds were analysed. The majority of cases (n = 146) were of 252 
the Swiss Brown (67%), Holstein-Frisian (12%) and Swiss Fleckvieh (11%) breeds. These 253 
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numbers reflect the over-all breed proportions of the patient population of the clinic. Single 254 
cases of Rhätisches Grauvieh, Dexter, Limousin and beef crossbreeds were also 255 
represented. The median age of the animals (n = 146) was 7 months, with a range from 2 256 
days to 6 years. Animals referred to the clinic (groups A and B, n = 86) were significantly 257 
older (median = 12 months) than those submitted directly for necropsy (group C, n = 60, 258 
median age = 2 months). Of the animals with a clinical record (n = 86), 26% had an age of 259 
24 months or over and four animals were older than three years (48, 52, 60 and 72 260 
months). The cases originated from 17 of the 26 Swiss cantons. Most of the cases (n = 261 
146) had a history of recurrent or untreatable diarrhoea (41%), pneumonia (20%) or both 262 
conditions together (9%). Neurological symptoms (10%) were often anamnestically 263 
described in necropsy reports of young calves, directly referred for post mortem 264 
examination (group C). Other anamnestic signs were abortion, lameness due to claw 265 
problems, anaemia and ill thrift. In 45% of the cases (n = 146) the anamnestic report 266 
indicated concomitant health problems in the herd. Growth retardation was indicated in 267 
30% of the cases.  268 
 269 
Clinical and post mortem findings 270 
The 12 most frequently observed clinical and post mortem manifestations are shown in 271 
Figure 1. Nearly all animals showed unspecific signs like loss of appetite (94%), reduction 272 
of the general condition (93%) and ruminal hypoperistalsis (92%), followed by intestinal 273 
disorders like diarrhoea (69%) and the resulting dehydration (63%). Respiratory sounds of 274 
different degree were present in 63% of the cases. Mucosal erosions as a more specific 275 
manifestation were found in the oral cavity and on the muzzle of 45% and 36% of the 276 
animals, respectively (Fig. 1A). For the determination of the most frequent post mortem 277 
findings, only cases with a complete necropsy report were included, whereas partial 278 
necropsies (e.g. single organs or body parts) were excluded (group C.2). Group D was 279 
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excluded, because the abortions were often in a condition that would no longer allow clear 280 
post mortem diagnosis or consisted only of foetal body parts. The most frequent necropsy 281 
findings differed between animals with clinical reports (groups A and B) and those referred 282 
directly for necropsy (group C.1) (Fig. 1B). In the latter, these were pathological changes in 283 
the lung, while alterations in one or more mucosal organs (from muzzle to large intestines) 284 
were the primary findings in the clinical cases. Generally, except for the lung, a higher 285 
proportion of cases referred to the clinic (groups A and B) showed macroscopic lesions 286 
than animals directly referred for a post mortem examination (group C.1).  287 
 288 
Haematological and microbiological findings 289 
Haematological data were available from 82 of the 86 cases with a clinical report (groups 290 
A and B). The most frequently observed changes were elevated bilirubin levels (89%) and 291 
monocytosis (88%), neutrophilia (in 74%) and leukocytosis (in 59% of the animals). 292 
Decreased leukocyte counts were found in 11% of the cases. Alterations in erythrocyte 293 
parameters were frequent and were displayed as polycythemia (73% of the animals), 294 
decreased cellular haemoglobin content (61%) and a decreased erythrocyte volume 295 
(59%). 296 
For groups A and B, intra vitam parasitological and bacteriological analyses were not 297 
performed routinely but rather upon clinical suspicion. However, with the exception of 298 
gastrointestinal nematodes that were present in 62% of the 47 cases analysed, parasites 299 
and bacteria such as liver fluke, lung worm, Salmonella, Campylobacter and enterotoxic 300 
E.coli were only occasionally confirmed (0-10% of analysed cases). Furthermore, all 30 301 
animals analysed for the presence of ovine herpesvirus-2, the causative agent of 302 
malignant catarrhal fever in cattle, were negative. Four and five animals were analysed for 303 
the presence of rota- and coronavirus, respectively. For each virus, one animal tested 304 
positive. Bovine herpesvirus-1 that can cause symptoms similar to BVD/MD is eradicated 305 
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in Switzerland and can be excluded as contributing factor to the symptoms observed. For 306 
all groups, post mortem parasitological and bacteriological analyses were performed 307 
sporadically, depending on demand and suspicion and were not included to the study. 308 
 309 
Comparison of mucosal lesions 310 
In many cases, mucosal lesions were observed at multiple locations of the gastrointestinal 311 
tract. To be able to compare the general degree of mucosal lesions between groups of 312 
animals, it was necessary to condense the multiple mucosal alterations to one parameter. 313 
We used the number of affected organs and the severity of the single alterations to 314 
calculate an index for each animal, referred to as mucosal (mc) index (see “Animals, 315 
Material and Methods” for details). The highest value that is theoretically possible (= all 316 
analysed organs are severely affected) is 21. The maximal and minimal mc index values 317 
observed from the 130 cases analysed (complete necropsy reports only: groups A, B and 318 
C.1) was 16 and 0, respectively, with an arithmetic mean of 1.9.  319 
Because intestinal and pulmonary symptoms were the most frequent findings observed in 320 
the BVDV infected animals, we investigated whether these findings were correlated. 321 
Interestingly, these organ manifestations tended to exclude each other. As shown in Fig. 322 
2A, animals with a high mucosal index had significantly less severe lung alterations than 323 
those with a low mucosal index. Moreover, animals with severe pulmonary manifestations 324 
were significantly younger than those with less severe pathological changes in the lungs 325 
(Fig. 2B). By contrast, the mucosal index was significantly higher in older animals than in 326 
young ones (Fig. 2C). Linear regression analysis (Spearman Rank) demonstrated a weak 327 
(ρ = 0.46) but statistically significant (p = 0.0003) correlation between the mc index and the 328 
age of the animals. 329 
  330 
Correlation between post mortem findings and presence of cp biotype 331 
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The dichotomy between lung and mucosal lesions pointed to roughly two groups of BVDV 332 
infected patients.  In order to investigate if this correlated with  the presence or absence of 333 
mucosal disease, we tested serum samples of 14 PI animals of group B for the presence 334 
of cytopathic (cp) virus by passaging different dilutions of the sera three times on cultured 335 
bovine turbinate cells. This analysis was restricted to 14 animals, since blood samples 336 
were only available from the prospective cases (group B) and young calves with maternal 337 
antibodies had to be excluded due to inhibition of virus isolation. The results are shown in 338 
Table 2. With one exception (04-06), the cp biotype was only present in sera of animals 339 
with an mc-index of ≥ 1.7, suggesting that these patients had suffered from MD. No cp 340 
biotype was observed in animals with an index of ≤ 0.9. Therefore, we decided to set the 341 
threshold between MD- and non-MD cases to 1.0. Extrapolating this finding to the mucosal 342 
indices of all cases, 40% of the animals (52 / 130) had suffered from MD.  343 
 344 
BVDV genetic subgroup analysis 345 
Of the 171 cases analysed in this work (groups A, B, C and D), the partial genomic 346 
sequence of the persisting virus was known from 155 cases (Bachofen et al., 2008). For 347 
the 18 cases of group B, viral RNA was isolated from blood, from the other cases from 348 
frozen tissue samples. Phylogenetic subgroup assessment was performed based of the 349 
5’untranslated region and in some cases additionally on the Npro coding region. The 350 
subgroups present are shown in Figure 3 B. The majority of the animals harboured viruses 351 
of the subgroups BVDV-1e (32%) and 1h (34%), followed by 1k (24%) and 1b (9%). From 352 
one single animal we isolated the BVD-1x virus as described previously (Bachofen et al., 353 
2008). These are (with exception of 1x) the same subgroups as described by Stalder et al. 354 
(2005) (Fig. 3 A). The subgroup 1e was most prominent in the latter (43%) while 1h was 355 
the most frequent subgroup in clinical cases (34%) (Figs. 3). However, statistical analysis 356 
revealed no significant differences of the proportions of BVDV subgroups present in the 357 
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diseased PI’s and animals detected persistently infected independent of their health 358 
condition. 359 
 360 
Comparison of BVDV subgroups and manifestations 361 
114 cases with a complete necropsy report and a known BVDV sequence could be 362 
included in this part of the study. This number is composed of 52 animals of group A, 18 of 363 
group B and the 45 cases of group C.1. The single animal harbouring BVDV 1x was 364 
excluded from the analysis, resulting in 114 PI animals. Of these, 7% had harboured 365 
viruses belonging to subgroup 1b, 34% to 1e and 1h each, and 25% to 1k (Fig. 4). 366 
We observed no statistically significant differences in the associations of viruses of a given 367 
subgroup with mucosal or pulmonary alterations or suspected MD cases (Fig. 4), nor did 368 
we see differences with regard to different age groups, breeds or other clinical, post 369 
mortem or haematological findings (data not shown). However, there was a tendency for 370 
1h viruses to be more frequently isolated from animals with mucosal problems, 371 
presumable MD cases (mucosal index ≥ 1), and thus older animals, while 1e was the 372 
predominant subgroup of BVD virus in patients with pulmonary alterations and thus 373 
younger animals (Fig. 4). To broaden the age range of the patients, we additionally 374 
analysed the proportions of the different BVDV-1 subgroups in the 25 cases of group D 375 
(abortions, stillbirths and neonates). Interestingly, we observed a clear predominance of 376 
representatives of subgroup 1e BVD viruses in these animals (Fig. 4). The subgroup 377 
proportions in group D were significantly different from those observed in animals with 378 
mucosal lesions and suspected MD cases (mc index ≥ 1).  379 
 380 
 381 
DISCUSSION 382 
 383 
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The spectrum and severity of clinical signs caused by BVDV infection are highly variable. 384 
Factors contributing to this complexity include two types of infection with entirely different 385 
involvement of the immune system (immune response in transient versus. 386 
immunotolerance in persistent infection), two different biotypes of virus (noncytopathic 387 
versus cytopathic) and the diverse genetic spectrum of BVDV as well as that of the host 388 
animals. Studies on the virulence of individual strains of BVDV focus on transient 389 
infections. Experimental infections and analysis of disease outbreaks in transiently infected 390 
animals characterised by particular signs and severity of disease clearly suggested an 391 
influence of the infecting viral strain on disease manifestation. For example, Baule et al. 392 
(2001) as well as Jones et al. (2004), have shown BVDV-1d strains to be associated with 393 
respiratory disease in acutely infected calves. Furthermore, Ridpath et al. (2007) could 394 
experimentally reproduce the clinical symptoms caused by virulent BVDV-1 strains in 395 
acutely infected heifers.  396 
In persistent infection, in contrast, analysis of a potential impact of the viral strain on the 397 
clinical picture is, for a number of reasons, more difficult. Among them is the existence of 398 
disease signs associated with persistent infection as such, and the occurrence of MD as a 399 
form of infection associated with the emergence of a cytopathic biotype of BVDV in these 400 
immunotolerant animals. Furthermore, some of the signs of persistent infection unrelated 401 
to MD may be of chronic nature, such as growth retardation and general ill-thrift. However, 402 
as shown by pluriparous PI cows and PI bulls detected among the candidates for artificial 403 
insemination stations, clinical signs of persistent infection can be absent in some animals. 404 
Experimental generation of a sufficient number of PI animals with different strains of BVDV 405 
would be laborious and require long-term follow-up. In addition, many different factors 406 
such as time point of maternal infection, genetic background of the animals and 407 
environmental factors, e.g. the presence of various other cattle pathogens, may modulate 408 
the outcome. Moreover, the epidemiological situation – endemic versus. non-endemic – 409 
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may influence the clinical appearance of infections. It is not surprising, therefore, that 410 
questions such as the impact of BVDV genetic properties on the health status of a PI 411 
animal, or possible associations between disease signs and a given subgroup of BVDV 412 
during this type of infection, have to date not been addressed. 413 
 414 
We have investigated these questions in an endemic situation that was virtually 415 
undisturbed by vaccination or other control measures, both of which might influence the 416 
outcome of infection. In order to obtain information on the pathogenic potential of BVDV in 417 
persistent infection, we analysed clinical and necropsy findings of diseased PI animals and 418 
compared the BVDV subgroups present in these animals those isolated from animals 419 
diagnosed as PI independently of the health status. 420 
Since we included prospective as well as retrospective cases examined over a period of 421 
ten years, the long time range and the fact that different clinicians and pathologists 422 
examined the animals might influence the comparability of the raw data. However, the 423 
protocol applied to both the clinical and pathological investigations did not change over this 424 
time. In addition, the fact that the initial examinations were performed by many different 425 
clinicians and pathologists decreases the risk of a systematic bias. Moreover, the 426 
transformation of nominal into numerical data was done by one person, using a 427 
standardised protocol.  428 
To obtain a larger number of cases, we analysed different groups of patients. While the 429 
retro- and prospective cases from the ruminants’ clinic (groups A and B) showed similar 430 
demographic parameters and post mortem findings (data not shown), we observed 431 
significant differences to the animals of group C. Animals of groups A and B were 432 
significantly older and generally more severely diseased than the cases directly referred 433 
for post mortem analysis (group C) (Fig. 1B). This might be due to the fact that, generally, 434 
the more valuable and thus primarily older animals with complex or unsuccessfully pre-435 
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treated health problems are referred for a stay at the clinic. The high proportion of females 436 
in groups A and B simply reflects the fact that most of these animals originate from dairy 437 
farms.  438 
Interestingly, also the main post mortem findings differed between groups A and B versus 439 
group C, with mucosal alterations playing a prominent role in groups A and B and 440 
pulmonary lesions in group C (Fig. 1B). Keeping in mind the age difference between the 441 
groups, we tested the statistical correlation between lung and mucosal manifestations and 442 
the age of the animals. Mucosal lesions were more frequent in older and lung lesions in 443 
younger animals (Figs. 2); that held also true when the two animal groups (A+B and C) 444 
were tested separately (data not shown). The reason for the correlation between age and 445 
the post mortem finding may be related to the higher risk of MD onset with increasing age. 446 
MD is correlated to the appearance of the cp virus that arises as a result of mutations or 447 
recombination during viral RNA replication from the persisting ncp virus (Deregt and 448 
Loewen, 1995; Neill and Ridpath, 2001; Lackner et al., 2004). Statistically, a longer time 449 
period of viral replication may increase the risk of generating mutations leading to a cp 450 
biotype. Due to the retrospective nature of the study, we were not in a position to fulfill the 451 
virological criterion for diagnosing MD by showing the presence of cytopathic and non-452 
cytopathic BVDV in all cases. To overcome this problem we combined a virological 453 
determination of MD of selected cases (namely the isolation of both biotypes) with a 454 
standardised pathological investigation (Table 2). The latter was achieved by creating a 455 
“mucosal (mc) index”, comparable to other clinical or pathological indices, e.g. the 456 
psoriasis area severity index (PASI) in human dermatology. Typically, MD leads to 457 
mucosal lesions at multiple locations of the digestive tract. Therefore, the mc index places 458 
more weight on the number of affected organs than on the severity of single lesions. This 459 
approach also minimizes individual differences in rating the severity of lesions and favours 460 
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completeness of the necropsy reports. The results of the comparison of the biotype 461 
analysis with the mc index (Table 2) support the validity of the concept. 462 
 463 
Taking all BVD viral sequences of groups A, B, C and D together, we did not observe 464 
statistically significant differences to the BVDV subgroup distribution previously  described 465 
by Stalder et al., 2005 (Figs. 3). With the exception of the single “orphan” BVD 1x strain, 466 
we found the same four BVD-1 subgroups in the diseased animals and in the PI animals 467 
sampled in the course of an epidemiological survey. Although sampled in the same time 468 
period, the two large groups of PI animals are not matched with respect to breed, age or 469 
gender. On the one hand, using unmatched hosts, only major differences in tropism and 470 
virulence would show up. The results of our study argue against such major differences 471 
between entire subgroups. On the other hand, this observation does not exclude that 472 
individual strains may differ in virulence and tropism, as shown for transient infections. 473 
 474 
A different aspect concerns possible BVDV subgroup affiliations with the two main clinical 475 
and pathological patterns observed, i.e. lung- versus gastrointestinaltract-centered. In this 476 
context, the possibility that these patterns might be influenced by the presence (or 477 
absence) of other pathogens needs to be considered. Such pathogens could include other 478 
viruses, bacteria and parasites. Viruses known to induce similar clinical signs and 479 
pathology, i.e. bovine herpesvirus-1 and ovine herpesvirus-2, can be excluded. The former 480 
is eradicated in Switzerland, and all PI animals suspected of suffering from malignant 481 
catarrhal fever tested negative for this lethal form of infection caused by ovine herpes 482 
virus-2 (Ackermann, 2005). Where data were available, we recorded additional 483 
bacteriological and parasitological examinations. However, in most cases the suspected 484 
infections were not confirmed.  485 
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We did not find a statistically significant association between a given BVD viral subgroup 486 
and the two major disease manifestations (Fig. 4), nor to any other clinical or mortem 487 
finding (data not shown). However, we observed a tendency for viruses of subgroup 1h to 488 
be more frequently isolated from animals with mucosal lesions, while 1e was the 489 
predominant subgroup in animals with lung alterations (Fig. 4). Regarding the age 490 
dependency of the mucosal and pulmonary manifestations (Figs. 2), the observed 491 
subgroup tendencies may well correlate to different age groups of PI animals rather than 492 
reflect a selective organ tropism. Indeed, 38% of the animals younger than seven months 493 
(7 months = median age of all animals analysed) harboured BVDV-1e, while this 494 
proportion was only 29% in older animals (≥ 7 months). Since all PI animals are infected 495 
as foetuses, animals infected with BVDV-1e may die younger than animals infected with 496 
other subgroups and are therefore less frequently observed among older animals. This is 497 
supported by the observation of a surprisingly high proportion of BVDV-1e strains in 498 
abortions, stillbirths and neonates (Fig. 4), which clearly encourages additional 499 
investigations. We can exclude that a 1e live vaccine may be responsible, since, as 500 
indicated above, vaccines are used only very infrequently, and a 1e vaccine is not licensed 501 
in Switzerland. Moreover, we can also exclude that a particular strain of 1e may cause 502 
these abortions because the sequence data indicate that genetically different strains were 503 
present in these animals (Bachofen et al., 2008). 504 
 505 
In summary, our study showed that, in an endemic situation, clinical cases of BVDV PI 506 
animals fall roughly in two distinct categories, with lung-centred pathology occurring mainly 507 
in young animals and mucosal pathology mainly in older animals. Moreover, even though 508 
we did not find evidence for one BVDV subgroup being generally more virulent during 509 
persistent infection, the epidemiologically unrelated concentration of 1e subgroup BVD 510 
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viruses in stillborn calves and aborted foetuses provides preliminary evidence that viruses 511 
of this subgroup may play a special role in prenatal and perinatal losses due to BVD virus.  512 
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TABLES 619 
 620 
Table 1 621 
List of cases included in this study 622 
 623 
Group  
Clinical 
report 
Necropsy report 
Sequence 
analysis 
A 
Retrospective cases 
1995-2003 
68 67 52 
     
B 
Prospective cases  
2004 + 2005 
18 18 18 
     
C 
Pathology only a  
1995-2005 
- 
60  
(C.1 b: 45; C.2 c: 15) 
60 
     
D 
Abortions/ Neonates d 
1995-2005 
- 25 25 
 624 
a euthanised or perished animals, referred directly to the Institute of Veterinary Pathology 625 
by private practitioners for post mortem analysis of the entire carcassb or of body 626 
parts/organs only c. There were no clinical reports available of these cases. 627 
d aborted foetuses / foetal body parts and euthanised or perished neonatal calves (<3 628 
days), referred directly to the Institute of Veterinary Pathology by private practitioners for 629 
post mortem analysis. There were no clinical reports available of these cases. 630 
  631 
28 
 
Table 2 632 
Comparison of mucosal-indices and BVDV biotypes isolated from sera of 14 PI animals of 633 
group A (Table 1). 634 
PI animal mc-index BVDV biotype 
04-06 0.14 Ncp + cp 
05-13 0.14 Ncp 
05-14 0.14 Ncp 
04-05 0.57 Ncp 
05-05 0.86 Ncp 
04-07 1.71 Ncp + cp 
05-04 1.71 Ncp + cp 
05-01 2.14 Ncp + cp 
05-03 2.86 Ncp + cp 
04-01 3.43 Ncp + cp 
05-12 4.57 Ncp + cp 
04-04 5.14 Ncp + cp 
05-10 5.14 Ncp + cp 
05-11 8.57 Ncp + cp 
 635 
These 14 animals were chosen due to availability of serum and absence of maternal 636 
antibodies. 637 
  638 
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FIGURE LEGENDS 639 
 640 
Figure 1  641 
A: The 12 most frequently observed clinical findings in 86 clinically examined BVDV 642 
positive animals (68 of group A and 18 of group B, Table 1). 643 
B: The 12 most frequently observed necropsy findings from PI animals submitted for post 644 
mortem examination from the clinic (black bars) or directly from private practitioners (grey 645 
bars). Only necropsies of entire carcasses were included. The animal groups indicated 646 
refer to Table 1. 647 
a one or multiple pathological alteration(s) of the mucosa of the whole alimentary tract, 648 
including nose and muzzle  649 
b one or multiple pathological alteration(s) of the mucosa of the gastro-intestinal tract 650 
c macroscopic alteration of the mediastinal or mesenterial lymph nodes. 651 
 652 
Figure 2 653 
A: Comparison of medians of BVDV positive animals showing different degrees of post 654 
mortem lung alterations (0 = no alteration, 1 = mild, 2 = moderate, 3 = severe alteration) in 655 
regard of the severity and spread of mucosal lesions (displayed as mucosal index) and (B) 656 
with respect to the age of the animals. C: Comparison of different age groups of animals 657 
examined in relation to the mucosal index. 658 
a 67 cases of group A, 18 cases of group B and 45 cases of group C (Table 1) 659 
 660 
Figure 3 661 
Comparison of the proportions of BVDV-1 subgroups isolated from PI animals diagnosed 662 
for epidemiological studies and independent of the health status (A) and from clinical 663 
cases (B). 664 
30 
 
a all cases of subgroups A, B, C and D where the viral genomic sequence was available. 665 
 666 
Figure 4 667 
Proportions of the four main Swiss BVDV subgroups isolated from different groups of PI 668 
animals. 669 
a Only complete necropsy reports were included: 52 cases of group A, 18 of group B and 670 
45 cases of group C (Table 1) = 115. However, one single animal harboured a virus that 671 
did not belong to any of the four subgroups analysed and was therefore not included (n = 672 
114).  673 
b 25 cases of group D (Table 1) 674 
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